fourth generation tkis for cml: asciminib
Published 6 years ago • 1.2K plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:46
asciminib versus other tkis in the frontline treatment of cml: the asc4first study
-
1:16
mechanisms of resistance to the tki asciminib in cml
-
3:08
asciminib plus traditonal tkis for chronic phase cml
-
1:46
benefits of second generation tkis for cml in the frontline
-
0:48
asciminib for the treatment of cml
-
0:58
asciminib has the potential to succeed where other tkis have failed in cml
-
1:22
unmet needs in cml: increasing treatment-free remission & accessibility to tkis
-
1:49
asc4kids: investigating asciminib for pediatric patients with cml
-
7:42
cml | chronic myeloid leukemia | cml causes | cml symptoms | cml diagnosis
-
4:59
biosignaling | tgf-β signaling pathway
-
10:07
insulin signaling cascade and downstream effects - biochemistry lesson
-
3:20
the current standard of care in cml and insights into the use of first- and second-generation tkis
-
1:03
phase i study of asciminib in patients with cp-cml carrying the t315i mutation
-
1:01
treatment-free remission after second-generation tki treatment in cml
-
3:19
differences between cml in children and adults & the potential of asciminib in pediatric patients
-
1:04
combining autophagy inhibitors with tkis in cml
-
5:26
real-world analysis: molecular monitoring and adherence patterns to tkis in older patients with cml
-
2:15
resistance/intolerance to second generation tkis in cml: what to do next?
-
1:24
considerations for tki choice in frontline and r/r cml
-
2:20
tkis in cll: an overview
-
0:58
optimizing treatment for ph all: tkis combined with chemotherapy followed by transplantation
-
1:13
the allg cml13 ascend-cml study: high major molecular responses with asciminib treatment for cp-cml